NCT00001790
- Conditions
- Agranulocytosis, Aspergillosis, Bacterial Infections and Mycoses, +19 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Inflammation. Study availability and eligibility vary by location and protocol.
NCT00001790
NCT00005912
NCT00001810
NCT00001937
NCT00481572
NCT00616876
NCT00609375
NCT00599794
NCT00100308
NCT00135291